The Malawi-Liverpool-Wellcome Clinical Research Programme (MLW) (https://www.mlw.mw) is an internationally recognised centre for medical research and research training, affiliated to the Malawi College of Medicine. MLW has 2 aims, to conduct excellent research to benefit health and trains the next generation of researchers in Malawi at its Blantyre based offices located within the vicinity of the largest hospital in Malawi, Queen Elizabeth Central Hospital (QECH. The programme has been in existence since 1995 and is funded through 5 yearly cycles.
The programme manages more than 100 grants at any point in time and currently has more than 750 staff in research and support functions (operations).
About the Wellcome Translational Partnership Grant
MLW is the largest science institution in Malawi and has a track record of world-changing translational success including HIV self-testing and rotavirus vaccination. MLW is organised in Research Groups, each of which has a translational science plan, a pipeline of trainees and a philosophy that we cannot afford waste — all research and training effort must be focused on impact
This is a grant which has been awarded to Malawi Liverpool Wellcome Trust by the Wellcome with the key aim of championing solutions to the question “How can science drive the health and wealth of Malawi?” While the programme is structured to promote translational science, it does not have specific institutional support for translational science for its researchers.
It is from this perspective that MLW seeks to engage a resource on part-time basis or through consultancy as a Translational Science Champion to help achieve this goal. The grant is expected to be implemented in the early quarter of 2020 (January or February) and will ran for 24 months. Key Performance Indicators to track progress are being developed.
Position: Translational Science Champion
MLW’s view of the ideal candidate is someone: